Residual Solvent Testing for Supplements — USP <467>

Nearly every botanical extract, flavor, and encapsulated ingredient in supplements was made using a solvent at some point. Residual solvents are the trace amounts of those processing solvents left behind in your finished product. USP <467> classifies solvents by toxicity and sets strict limits. Testing by GC headspace is straightforward, but knowing which solvents to test for and what the limits mean requires understanding the classification system.

Quick answer

USP <467> classifies residual solvents into three classes. Class 1 solvents (benzene, carbon tetrachloride, 1,2-dichloroethane) are carcinogenic and should never be present. Class 2 solvents (methanol, hexane, toluene, methylene chloride) have defined PDE (permitted daily exposure) limits and should be controlled. Class 3 solvents (ethanol, acetone, ethyl acetate) are low-toxicity and limited by GMP. A standard USP <467> residual solvent screen by GC headspace costs $150-350 per sample with 5-7 business day turnaround.

USP <467> solvent classification

USP <467> adopts the ICH Q3C guideline on residual solvents and divides them into three classes based on toxicity:

Class 1 solvents: solvents to be avoided

These are known or strongly suspected human carcinogens and environmental hazards. They have no therapeutic benefit and should never be present in a dietary supplement. If detected, an investigation is mandatory.

Class 2 solvents: solvents to be limited

These are non-genotoxic animal carcinogens or solvents with other significant but reversible toxicities. They are assigned PDE limits based on toxicological data. They may be used in manufacturing but must be controlled to below PDE levels.

Class 3 solvents: low toxic potential

These solvents have low toxic potential. PDEs of 50 mg/day or more are accepted without further justification. Limits are typically set by GMP (not more than 5,000 ppm or 0.5% unless justified).

How GC headspace testing works

The standard method for residual solvent analysis is gas chromatography with headspace sampling (GC-HS), following USP <467> Procedure A or B.

The process:

1. A weighed sample is placed in a sealed headspace vial.
2. The vial is heated (typically 80-105 degrees C for 30-60 minutes). Volatile solvents partition into the headspace gas above the sample.
3. A known volume of the headspace gas is injected onto a GC column.
4. Solvents separate by boiling point and polarity on the column (typically a 624-type or G43-type column).
5. Detection is by flame ionization detector (FID) for routine analysis or mass spectrometry (MS) for confirmation.
6. Quantitation uses external standard calibration or standard addition to compensate for matrix effects.

The GC-HS method can screen for 20-40 common Class 1, Class 2, and Class 3 solvents in a single run. Reporting limits are typically 10-50 ppm depending on the solvent. Class 1 solvents are reported at the 1-10 ppm level.

⚠️ Note

A standard USP <467> residual solvent screen does NOT include ethylene oxide. Ethylene oxide is a fumigant, not a processing solvent, and requires a separate GC-MS method. If your botanical ingredients are sourced from India, Southeast Asia, or the Middle East, request a separate ethylene oxide test.

When residual solvent testing is needed

Residual solvent testing is most relevant for these product types:

Typical cost and turnaround

Common mistakes in residual solvent testing

1. Testing the wrong product. Testing a hard tablet for residual solvents when the solvent risk is in the botanical extract, not the finished dosage form. Test the ingredient where the solvent was used.

2. Not adjusting for serving size. A solvent result of 500 ppm in a 500 mg capsule equals 0.25 mg per serving. The PDE for that solvent might be 5 mg/day. You are well under the limit even though 500 ppm sounds high. Always calculate per-serving exposure and compare to the PDE.

3. Ignoring Class 3 solvents. While Class 3 solvents have less stringent limits, levels above 5,000 ppm (0.5%) are considered excessive by GMP standards. A botanical extract with 8,000 ppm (0.8%) ethanol may have been improperly dried and could fail a specification check.

4. Using a method validated for drug products, not supplements. USP <467> was written for pharmaceutical products. The extraction procedure and matrix effects may differ for supplement matrices (high-fat, high-protein, complex botanical blends). Confirm the method is validated for your specific matrix.

💡 Note

If your supplier's COA lists "residual solvents: complies with USP <467>" without listing which solvents were tested and at what levels, ask for the raw data. "Complies" means nothing without knowing which solvents were screened and what the detection limits were.

Related guides

• Heavy metal testing for supplements
• Pesticide testing for supplements
• Finished product testing requirements
• Supplement testing cost guide
• Sourcing clean ingredients

FAQ

Q: Does FDA require residual solvent testing on every supplement lot?

A: Not explicitly for every lot. 21 CFR 111 requires that you establish specifications for purity and that you verify those specifications are met. If residual solvents are part of your purity specification, you must test at a frequency justified by your risk assessment. The first batch of a new ingredient should always be tested. Ongoing frequency can be reduced under a documented skip-lot program.

Q: What is the difference between Procedure A and Procedure B in USP <467>?

A: Procedure A is for water-soluble samples. Procedure B is for water-insoluble samples (most supplements), using DMF or DMSO as the sample solvent. Most supplement labs use Procedure B. The choice affects which solvents can be reliably detected, as the sample solvent can mask early-eluting peaks.

Q: Can I test for residual solvents in-house?

A: Yes, if you have a GC with a headspace autosampler and trained personnel. A basic GC-HS system costs $30,000-60,000. However, most supplement brands outsource residual solvent testing to contract labs because the instrument is expensive, the method requires skilled operators, and you typically test only a few samples per year.

Q: What happens if I detect a Class 1 solvent?

A: This is a serious finding. Immediately quarantine the affected ingredient lot and any finished product made from it. Investigate the source. Notify your supplier. File a formal OOS investigation per your GMP procedures. Consider whether a voluntary recall is necessary. FDA considers any detectable level of a Class 1 solvent to be adulteration.

Q: Do softgels need residual solvent testing?

A: Possibly, but focus on the fill material, not the gelatin shell. The fill material (oil, extract, suspension) is more likely to contain residual solvents from active ingredient extraction or flavor preparation. The gelatin shell manufacturing process (water-based) introduces minimal solvent risk. Test the fill material directly.

Quick Reference

Lab Category: Residual Solvent Analysis / GC Headspace

Method: USP <467> (Procedure A for water-soluble, Procedure B for water-insoluble)

Instrument: Gas chromatograph with headspace autosampler (GC-HS) with FID or MS detection.

Sample requirements: 5-25 g of ingredient or finished product.

Turnaround: 5-7 business days standard; 2-4 business days rush.

Accreditation: ISO 17025 with USP <467> on the scope of accreditation. Verify the lab's scope covers dietary supplement matrices, not just pharmaceutical products.

Pricing:

Regulatory standards: USP <467> (US), ICH Q3C (International), European Pharmacopoeia Chapter 5.4, Amazon Supplement Compliance Requirements.

Get lab testing quotes →